Neurology

Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical OfficerCapricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer

Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer

— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in neuromuscular…

1 month ago
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101

Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101

- BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model - - The DBA/2 model is…

1 month ago
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging DataNexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data

HOUSTON, TX, May 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader…

1 month ago
Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and CollaborationCritical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration

Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration

TUCSON, Ariz., May 8, 2025 /PRNewswire/ -- The year 2025 marks a historic milestone for Critical Path Institute® (C-Path), as the…

1 month ago
Zilia Closes Bridge Round with Participation from Existing and New Investors Including Linearis VenturesZilia Closes Bridge Round with Participation from Existing and New Investors Including Linearis Ventures

Zilia Closes Bridge Round with Participation from Existing and New Investors Including Linearis Ventures

QUEBEC CITY, May 7, 2025 /PRNewswire/ - Zilia Inc. (''Zilia''), a medical technology company pioneering the use of the eye…

1 month ago
Pramana Strengthens Scientific Leadership with Addition of Dr. Adrian Noriega to Advance Neurodegenerative PipelinePramana Strengthens Scientific Leadership with Addition of Dr. Adrian Noriega to Advance Neurodegenerative Pipeline

Pramana Strengthens Scientific Leadership with Addition of Dr. Adrian Noriega to Advance Neurodegenerative Pipeline

VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Pramana Pharmaceuticals, a late-stage preclinical biopharmaceutical company developing a transformative small…

1 month ago
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA CongressAlterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

ATH434 Phase 2 Data to be Presented at Opening Plenary SessionMELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE)…

1 month ago
Clene Reports First Quarter 2025 Financial Results and Recent Operating HighlightsClene Reports First Quarter 2025 Financial Results and Recent Operating Highlights

Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights

Clene preparing for upcoming meeting in the second quarter with the U.S. Food and Drug Administration (FDA) to reach agreement…

1 month ago
Clario Announces Completion of Acquisition of WCG’s eCOA BusinessClario Announces Completion of Acquisition of WCG’s eCOA Business

Clario Announces Completion of Acquisition of WCG’s eCOA Business

Clario strengthens its leadership in digital endpoint data collection with the acquisition of WCG's eCOA business, enhancing support for neuroscience…

1 month ago
Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputerLundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer

Lundbeck joins forces with Danish Centre for AI Innovation to improve brain health by advancing drug discovery with Gefion AI supercomputer

VALBY, Denmark, May 6, 2025 /PRNewswire/ -- H. Lundbeck A/S is pleased to announce its agreement with the Danish Centre for AI…

1 month ago